France· FR:63941426
PYLERA 140 mg/125 mg/125 mg, gélule
A medicinal product containing métronidazole + chlorhydrate de tétracycline + sous-citrate de bismuth potassique, registered in France by LABORATOIRES JUVISE PHARMACEUTICALS, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- MÉTRONIDAZOLE + CHLORHYDRATE DE TÉTRACYCLINE + SOUS-CITRATE DE BISMUTH POTASSIQUE
- Manufacturer
- LABORATOIRES JUVISE PHARMACEUTICALS
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip133400921804201flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 120 gélule(s)EUR 50.48
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Métronidazole + chlorhydrate de tétracycline + sous-citrate de bismuth potassique in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandPyleraDelfarma Sp. z o.o.
- United StatesBismuth Subcitrate Potassium, Metronidazole and Tetracycline HydrochloridePar Health USA, LLC
- GermanyPyleraLaboratoires Juvise Pharmaceuticals
- SwitzerlandPylera 140 mg/125 mg/125 mg, HartkapselnMedius AG
- IrelandPylera 140 mg/125 mg/125 mg capsules, hardLaboratoires Juvise Pharmaceuticals
- SwedenPylera 140 mg/125 mg/125 mg Kapsel, hårdLaboratoires Juvise Pharmaceuticals
- FinlandPyleraLaboratoires Juvise Pharmaceuticals
- CzechiaPYLERALaboratoires Juvisé Pharmaceuticals, Villeurbanne
Authorised across Europe · EMA
The same active substance is authorised in 22 EEA countries. Names it is sold under:
- Austria · Pylera
- Belgium · Tryplera
- Bulgaria · Pylera
- Czechia · Pylera
- Germany · Pylera
- Denmark · Pylera
- Estonia · Pylera
- Spain · Pylera
- Finland · Pylera
- United Kingdom (Northern Ireland) · Pylera
- Ireland · Pylera
- Italy · Pylera
- Lithuania · Pylera
- Luxembourg · Tryplera
- Latvia · Pylera
- Malta · Pylera
- Norway · Pylera
- Poland · Pylera
- Portugal · Pylera
- Romania · Pylera
- Sweden · Pylera
- Slovakia · Pylera
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/94f45919-35e1-4d7f-8486-922e5e94e28f GET /v1/drugs/94f45919-35e1-4d7f-8486-922e5e94e28f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "63941426",
"date_amm": "2012-01-16",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"substance": "MÉTRONIDAZOLE + CHLORHYDRATE DE TÉTRACYCLINE + SOUS-CITRATE DE BISMUTH POTASSIQUE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "gélule",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about métronidazole + chlorhydrate de tétracycline + sous-citrate de bismuth potassique.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.